Multiple Myeloma Prognosis After Stem Cell Transplant

See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic.

Multiple myeloma prognosis after stem cell transplant.

It isn t a cure but compared to chemotherapy alone a. Multiple myeloma patient don kendall had a pretty good idea what to expect when he began his stem cell transplant in january 2014. That s because he was undergoing his second transplant within six months as part of a clinical trial at the md anderson stem cell transplantation and cellular therapy center. A stem cell transplant replaces unhealthy blood cells with healthy ones.

It was january 2011 when i received my multiple myeloma diagnosis. Right now i feel perfectly normal but can t get my head around nobody being able to tell me how long i ve got. Autologous stem cell transplant can provide significant remission that is both long and deep extending survival. Stem cell transplant is commonly used to treat multiple myeloma.

I have taken part in the myeloma xi trial and also had a stem cell transplant using my twin brothers clean cells. 1 a surveillance epidemiology and end results seer based analysis of long term survival in mm patients reported steady improvements over time with 5 year relative survival peaking at 34 7 in 2002 through. The transplant of this kind is the standard treatment for patients with various myeloma. The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival.

Don 64 was able to complete virtually all his treatment as an outpatient and almost. The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review study reports. Older patients and those with low risk disease show the greatest gains over time while people with high risk factors showed the least change its researchers said. It can be a strong weapon in your fight against multiple myeloma.

We here analyze factors influencing survival in 865 newly diagnosed mm patien. Since the introduction of novel therapies approximately 2 decades ago we have seen substantial improvements in the outcomes of patients with newly diagnosed multiple myeloma mm. The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy.